97/100BAccenture stock forecast 2027–2031What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Accenture is 230.05, 9.2% below the current price of 253.49. Their targets range from 175.00 to 278.00.
Of the 19 firms that rated Accenture in the past 12 months, 9 rate it buy or strong buy, 10 hold and 0 sell or strong sell (each firm at its latest rating): a Hold consensus.
Analysts' 1-year price targets range from 175.00 to 278.00, with an average of 230.05.
| Buy | 9 | |
| Hold | 10 | |
| Sell | 0 |
12-month price target
| Highest target | 278.00 |
| Average target | 230.05 |
| Lowest target | 175.00 |
| Current price | 253.49 |
Accenture price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Accenture price target and rating?
How analysts rate Accenture, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
9 of 19 firms rate it buy now, against 13 of 18 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Accenture analyst upgrades, downgrades and price targets
The latest rating change came on 21 October 2026, when Baird downgraded Accenture from Outperform to Neutral. The most recent new target came from Wells Fargo on 26 October 2026: 252.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 26 Oct 2026 | Wells Fargo Jason Kupferberg | Reiterated · Equal Weight | 210.00 → 252.00 | +20.0% | 249.37 |
| 21 Oct 2026 | Robert W. Baird David Koning | — | 245.00 → 252.00 | +2.9% | 239.12 |
| 21 Oct 2026 | Baird | Downgraded · Outperform → Neutral | — | — | — |
| 15 Oct 2026 | Stifel Nicolaus David Grossmam | — | 270.00 → 242.00 | -10.4% | 226.95 |
| 15 Oct 2026 | UBS | — | 275.00 → 278.00 | +1.1% | 227.28 |
| 15 Oct 2026 | Susquehanna | Reiterated · Neutral | 210.00 → 230.00 | +9.5% | 214.96 |
| 6 Oct 2026 | Mizuho Securities Dan Dolev | Reiterated · Outperform | 226.00 → 241.00 | +6.6% | 195.05 |
| 2 Oct 2026 | Truist Financial Arvind Ramnani | Reiterated · Hold | 150.00 → 220.00 | +46.7% | 202.59 |
| 2 Oct 2026 | RBC Capital David Paige | Reiterated · Outperform | 195.00 → 240.00 | +23.1% | 204.00 |
| 2 Oct 2026 | Argus Research | Reiterated · Buy | 260.00 | — | 204.03 |
| 2 Oct 2026 | BMO Capital | — | 200.00 → 235.00 | +17.5% | 212.30 |
| 2 Oct 2026 | Morgan Stanley James Faucette | Reiterated · Equal Weight | 175.00 → 195.00 | +11.4% | 212.30 |
| 2 Oct 2026 | Wells Fargo Jason Kupferberg | Reiterated · Equal Weight | 194.00 → 210.00 | +8.2% | 212.30 |
| 2 Oct 2026 | Jefferies Surinder Thind | — | 220.00 | — | 212.30 |
| 1 Oct 2026 | Goldman Sachs | — | 270.00 → 260.00 | -3.7% | 212.30 |
| 1 Oct 2026 | Susquehanna | — | 153.00 → 210.00 | +37.3% | 214.69 |
| 1 Oct 2026 | Robert W. Baird | — | 190.00 → 245.00 | +28.9% | 214.75 |
| 1 Oct 2026 | Evercore ISI | — | 180.00 → 250.00 | +38.9% | 216.10 |
| 28 Sept 2026 | Susquehanna | Reiterated · Neutral | 140.00 → 153.00 | +9.3% | 173.30 |
| 23 Sept 2026 | BMO Capital Keith Bachman | Reiterated · Market Perform | 150.00 → 200.00 | +33.3% | 183.72 |
| 18 Sept 2026 | Deutsche Bank | Reiterated · Hold | 136.00 → 175.00 | +28.7% | 183.53 |
| 18 Sept 2026 | Guggenheim | Downgraded · Buy → Neutral | — | — | — |
| 15 Sept 2026 | RBC Capital | — | 175.00 → 195.00 | +11.4% | 195.00 |
| 14 Sept 2026 | Morgan Stanley | Reiterated · Equal Weight | 130.00 → 175.00 | +34.6% | 189.15 |
| 14 Sept 2026 | Wells Fargo | Downgraded · Overweight → Equal Weight | — | — | — |
| 25 Aug 2026 | Wolfe Research | Reiterated · Outperform | 200.00 → 215.00 | +7.5% | 186.53 |
| 20 Jul 2026 | Wells Fargo | Reiterated · Overweight | 200.00 → 194.00 | -3.0% | 143.57 |
| 10 Jul 2026 | Deutsche Bank Nate Svensson | — | 265.00 → 136.00 | -48.7% | 139.06 |
| 8 Jul 2026 | UBS Kevin McVeigh | — | 320.00 → 275.00 | -14.1% | 139.72 |
| 23 Jun 2026 | Mizuho Securities | Reiterated · Outperform | 309.00 → 226.00 | -26.9% | 124.83 |
| 22 Jun 2026 | Susquehanna | Reiterated · Neutral | 277.00 → 140.00 | -49.5% | 125.61 |
| 22 Jun 2026 | Morgan Stanley | Reiterated · Equal Weight | 177.00 → 130.00 | -26.6% | 127.98 |
| 22 Jun 2026 | Truist Financial | Reiterated · Hold | 210.00 → 150.00 | -28.6% | 127.98 |
| 22 Jun 2026 | RBC Capital Daniel Perlin | Reiterated · Outperform | 300.00 → 175.00 | -41.7% | 127.98 |
| 22 Jun 2026 | Guggenheim | Reiterated · Buy | 285.00 → 185.00 | -35.1% | 127.98 |
| 22 Jun 2026 | Wells Fargo Jason Kupferberg | — | 275.00 → 200.00 | -27.3% | 127.98 |
| 22 Jun 2026 | TD Cowen | Downgraded · Buy → Hold | — | — | — |
| 19 Jun 2026 | BMO Capital Keith Bachman | — | 300.00 → 150.00 | -50.0% | 127.98 |
| 18 Jun 2026 | Robert W. Baird | — | 330.00 → 190.00 | -42.4% | 127.67 |
| 18 Jun 2026 | Evercore ISI | Reiterated · Outperform | 300.00 → 180.00 | -40.0% | 127.05 |
| 17 Jun 2026 | Berenberg Bank | — | 313.00 → 220.00 | -29.7% | 165.52 |
| 16 Jun 2026 | Wolfe Research Darrin Peller | — | 200.00 | — | 165.36 |
| 15 Jun 2026 | Morgan Stanley James Faucette | Downgraded · Overweight → Equal Weight | 320.00 → 177.00 | -44.7% | 170.28 |
| 8 Jun 2026 | Oppenheimer | — | 201.00 | — | 178.25 |
| 3 Jun 2026 | Stifel Nicolaus David Grossman | Reiterated · Buy | 270.00 | — | 186.22 |
| 3 Jun 2026 | Goldman Sachs James Schneider | Reiterated · Buy | 330.00 → 270.00 | -18.2% | 186.22 |
| 1 Jun 2026 | Truist Financial Arvind Ramnani | Downgraded · Buy → Hold | 317.00 → 210.00 | -33.8% | 187.07 |
| 5 Mar 2026 | Piper Sandler | — | 282.00 | — | 210.00 |
| 17 Feb 2026 | Wells Fargo | Upgraded · Equal Weight → Overweight | — | — | — |
| 22 Jan 2026 | Berenberg Bank | — | 313.00 | — | 280.72 |
Accenture EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Accenture's EPS to grow 8.5% a year until 2029, about as fast as over the last 5 years (8.2% a year) and the last 3 years (8.0%).
Analysts expect Accenture's revenue to grow 5.0% a year until 2029, about as fast as over the last 5 years (8.0% a year) and the last 3 years (5.0%).
Revenue
EPS
Does Accenture beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 3.0% off the result, either way, and their revenue estimate 1.2%, over the last 12 quarters.
- EPS beats
- 83 / 101
- Revenue beats
- 83 / 100
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +2.9%
- Since
- October 2001
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q4 FY2026 | 1 Oct 2026 | 3.18 | 3.29 | +3.5% | 18.03B | 18.68B | +3.6% |
| Q3 FY2026 | 18 Jun 2026 | 3.70 | 3.80 | +2.7% | 18.78B | 18.72B | -0.3% |
| Q2 FY2026 | 19 Mar 2026 | 2.86 | 2.93 | +2.4% | 17.84B | 18.04B | +1.1% |
| Q1 FY2026 | 18 Dec 2025 | 3.74 | 3.94 | +5.3% | 18.53B | 18.74B | +1.2% |
| Q4 FY2025 | 25 Sept 2025 | 2.98 | 3.03 | +1.7% | 17.38B | 17.60B | +1.3% |
| Q3 FY2025 | 20 Jun 2025 | 3.30 | 3.49 | +5.8% | 17.32B | 17.73B | +2.3% |
| Q2 FY2025 | 20 Mar 2025 | 2.81 | 2.82 | +0.4% | 16.62B | 16.66B | +0.2% |
| Q1 FY2025 | 19 Dec 2024 | 3.42 | 3.59 | +5.0% | 17.15B | 17.69B | +3.2% |
| Q4 FY2024 | 26 Sept 2024 | 2.78 | 2.79 | +0.4% | 16.37B | 16.41B | +0.2% |
| Q3 FY2024 | 20 Jun 2024 | 3.15 | 3.13 | -0.6% | 16.54B | 16.47B | -0.5% |
| Q2 FY2024 | 21 Mar 2024 | 2.66 | 2.77 | +4.1% | 15.85B | 15.80B | -0.3% |
| Q1 FY2024 | 19 Dec 2023 | 3.14 | 3.27 | +4.1% | 16.17B | 16.22B | +0.3% |
Accenture stock price 2027–2031: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Accenture's earnings keep growing at the 7.5% a year analysts expect to FY2029, it would earn about 20.04 a share in FY2031. At the P/E it has traded at over the last five years (13.9 to 29.7) that is 278.35 to 595.17 a share, or 465.52 at its average P/E of 23.2. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2027 | 14.68 | 203.90 | 341.00 | 435.98 |
| FY2028 | 15.95 | 221.55 | 370.53 | 473.73 |
| FY2029 | 17.34 | 240.88 | 402.86 | 515.07 |
| FY2030 (extrapolated) | 18.64 | 258.94 | 433.06 | 553.67 |
| FY2031 (extrapolated) | 20.04 | 278.35 | 465.52 | 595.17 |
Each year's EPS is the analysts' consensus to FY2029; the years after grow 7.5% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (13.9, 23.2, 29.7).
Is Accenture stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Accenture's P/E of 18.6 is near the bottom of its 5-year range (9.9 to 42.5, median 26.9). Analysts do not expect slower growth than in recent years, so it is cheaper than its usual level. Buyers pay less for each point of growth than usual: a PEG of 2.2 on expected growth against 3.3 on its median P/E and past five years' growth. At its usual P/E (26.9 × EPS of 13.66), Accenture's fair value is 367.98; the price, 253.49, is 31.1% below it. Its forward P/E, on the consensus for FY2027, is 17.3.
Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (9.9 and 42.5). The price against its P/E range
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 18.56
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 26.94
- Five-year P/E range
- 9.9 – 42.5
- Forward P/E (FY2027)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 17.27
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 2.48
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- -9.2%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 235.690 | 464.49205Price 235.69627 | +97.1% | |
| 28.860 | 56.2634Price 28.8696 | +94.9% | |
| 199.110 | 384.58163Price 199.112,644 | +93.1% | |
| 123.990 | 237.24178Price 123.99297 | +91.3% | |
| 157.820 | 297.58169Price 157.82471 | +88.6% | |
| 162.670 | 305.52160Price 162.67396 | +87.8% | |
| 216.610 | 405.38304Price 216.61507 | +87.1% |
Furthest below the fair value on each stock's page, updated every day.